Beranda › Penyakit Autoimun › California

Uji klinis Penyakit Autoimun di California

27 studi untuk Penyakit Autoimun mencari peserta di lokasi di California.

Kota di California

Teks studi resmi (Bahasa Inggris)

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

City of Hope Comprehensive Cancer Center, Duarte

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06817889

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Jade Clinical Site, Chula Vista

Menerima pesertaFase 2

Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07541287

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

University of California Davis Comprehensive Cancer Center, Sacramento

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
University of California San Diego Center for Bleeding and Clotting Disorders, San Diego

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06722235

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

University of California Irvine - Accepting Adult Patients, Orange
University of California, San Francisco Benioff Children's Hospital - Accepting Young Adult and Juvenile Patients, San Francisco

Menerima pesertaFase 2/3

Usia 6 hingga 75 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06154252

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

University of Southern California, Los Angeles

Menerima pesertaFase 3

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07059000

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Loma Linda University Medical Center, Loma Linda

Menerima pesertaFase 1

Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
University of California San Diego Center for Bleeding and Clotting Disorders, San Diego

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06948318

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

GSK Investigational Site, Los Angeles
GSK Investigational Site, Los Angeles
GSK Investigational Site, Orange
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06572384

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

University of California Irvine, Orange
UC Davis Health, Sacramento

Menerima pesertaFase 1/2

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06121297

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

University of California Irvine, Orange
UC Davis, Department of Neurology, Sacramento
University of California, San Francisco, San Francisco

Menerima pesertaFase 1/2

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06359041

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

UC Irvine, Irvine
Orso Health, La Jolla
University of California, Los Angeles-UCLA, Los Angeles

Menerima pesertaFase 3

Usia 12 ke atas · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06056297

Study of BHV-1300 in Graves' Disease

Site-103, South Gate

Menerima pesertaFase 1

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06980649

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Site Number - 1010, Carlsbad
Site Number - 1028, Irvine
Site Number - 1023, Los Angeles
dan 2 lainnya

Menerima pesertaFase 3

Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07039916

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

Ronald Reagan UCLA Medical Center, Los Angeles
University of California, Irvine, Orange
Stanford University Medical Center, Palo Alto

Menerima pesertaFase 2/3

Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06193889

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

City of Hope, Duarte
Children's Hospital of Los Angeles, Glendale
Scripps Green Hospital, La Jolla
dan 8 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis

UCSF Medical Center, San Francisco
Stanford Medical Center, Stanford

Menerima pesertaFase 1

Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06201416

Atacicept in Multiple Glomerular Diseases

Vera Therapeutics, Brisbane

Menerima pesertaFase 2

Usia 2 ke atas · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06983028

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

Stanford University, Dept. of Dermatology, Redwood City
UC Davis, Dept. of Dermatology, Sacramento

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT04422912

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

Wallace Rheumatic Center, Beverly Hills
Providence Medical Foundation, Fullerton
University of California Irvine, Irvine
dan 2 lainnya

Menerima pesertaFase 1

Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06308978

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis

Stanford Multiple Sclerosis Center, Palo Alto

Menerima pesertaFase 1

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT06138132

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

UCLA Medical Center, Los Angeles
University of California, Irvine, Orange
Stanford Hospital, Palo Alto

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT06626919

Central Vein Sign in Multiple Sclerosis Extension Study

Cedars-Sinai Medical Center, Los Angeles

Menerima peserta

Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT07424027

CD4^LVFOXP3 in Participants With IPEX

Lucile Packard Children's Hospital, Palo Alto

Menerima pesertaFase 1

4 Months – 35 Years · Pria · Diperbarui 22 Mei 2025 · NCT05241444

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

University of California, San Diego, La Jolla

Menerima pesertaStudi observasional

Semua usia · Wanita · Diperbarui 28 Jan 2025 · NCT02103361

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

MiraKind, Los Angeles

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2025 · NCT02253251

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City

Menerima pesertaFase 1/2Sukarelawan sehat diterima

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2022 · NCT04684602

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.